Skip to main content
OpenTrials
Completed

NCT Number: NCT02029625

Compare the Pharmacokinetics of NVP-1205 and Coadministration of Rosuvastatin and Ezetimibe

The purpose of this study is to compare the pharmacokinetics of NVP-1205 and coadministration of rosuvastatin and ezetimibe.

Completed

Looking for future studies?

Notify Me

Key information

Age range

19 year–55 year

Sex eligibility

Male

Study type

Interventional

Phase

Phase 1

Primary location

Kyungpook National Hospital

Jung-gu, Daegu, 700-721, South Korea

About this study

rosuvastatin and ezetimibe(anti-dyslipidemia)

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Healthy male subjects age between 19 and 55 signed informed consent

Exclusion criteria

  • subjects have a history of allergy reaction of this drug or other drugs

Treatment and study plan

NVP-1205

Drug

rosuvastatin/ezetimibe fixed dose combination orally, once daily on Period 1 or Period 2

Other names: NVP-1205(rosuvastatin+ezetimibe)

Rosuvastatin and Ezetimibe

Drug

coadministration of rosuvastatin and ezetimibe orally, once daily on Period 1 or Period 2

Other names: Crestor and Ezetrol

Primary outcomes

  1. AUClast

    Time frame: 0-96hr

Secondary outcomes

  1. AUCinf

    Time frame: 0-96hr

Sponsors and collaborators

Lead sponsor

NVP Healthcare

Industry

Registry information

Official study title

A Clinical Trial to Compare the Pharmacokinetics and Safety of NVP-1205 and Coadministration of Rosuvastatin and Ezetimibe in Healthy Male Volunteers

Acronym: NVP-1205

Important dates

Study start
2014
Primary completion
2014
Study completion
2014
First posted
Jan 8, 2014
Registry last updated
Mar 25, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.